Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neothetics NEOT

Healthcare Biotechnology
"Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients."

Recent & Breaking News (NDAQ:NEOT)

Evofem Announces Closing Of Merger With Neothetics

PR Newswire January 17, 2018

Neothetics Announces Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Merger With Evofem

GlobeNewswire January 5, 2018

Recent Analysis Shows Aflac, Biogen, Oasis Petroleum, Twilio, Neothetics, and McDonald's Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire November 29, 2017

Neothetics Provides Business Update and Reports Third Quarter 2017 Financial Results

GlobeNewswire November 8, 2017

Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company

GlobeNewswire October 17, 2017

Biotech Stocks on Investors' Radar -- Neothetics, Pieris Pharma, and Repros Therapeutics

PR Newswire September 27, 2017

Neothetics Announces Review of Strategic Alternatives

GlobeNewswire July 10, 2017

12 Biggest Mid-Day Losers For Monday

Benzinga.com  June 26, 2017

Mid-Day Market Update: NASDAQ Turns Negative; Sparton Shares Spike Higher

Benzinga.com  June 26, 2017

Neothetics Announces Top-Line Results for Phase 2 Proof-of-Concept Study of LIPO-202 for the Reduction of Submental Subcutaneous Fat

GlobeNewswire June 26, 2017

Neothetics Provides Business Update and Reports First Quarter 2017 Financial Results

GlobeNewswire May 11, 2017

Neothetics to Provide a Business Update and Release First Quarter 2017 Financial Results Thursday, May 11th, 2017

GlobeNewswire May 4, 2017

Mid-Morning Market Update: Markets Open Higher; Walgreens Sales Miss Views

Benzinga.com  April 5, 2017

Neothetics Announces Issuance by USPTO of Eighth Patent Directed to LIPO-202 Lead Clinical Asset

GlobeNewswire April 5, 2017

Neothetics to Present at the 16th Annual Needham Healthcare Conference

GlobeNewswire March 29, 2017

Neothetics Provides Business Update and Reports Fourth Quarter 2016 Financial Results

GlobeNewswire March 23, 2017

Neothetics Announces Last Subject Enrolled in Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat

GlobeNewswire March 20, 2017

Neothetics to Provide a Business Update and Release Fourth Quarter 2016 Financial Results Thursday, March 23, 2017

GlobeNewswire March 16, 2017

15 Biggest Mid-Day Gainers For Friday

Benzinga.com  December 23, 2016

Mid-Day Market Update: Dipexium Surges On Merger News; Bonanza Creek Energy Shares Decline

Benzinga.com  December 23, 2016